Literature DB >> 12391185

Clonal deletion of simian virus 40 large T antigen-specific T cells in the transgenic adenocarcinoma of mouse prostate mice: an important role for clonal deletion in shaping the repertoire of T cells specific for antigens overexpressed in solid tumors.

Xincheng Zheng1, Jian-Xin Gao, Huiming Zhang, Terrence L Geiger, Yang Liu, Pan Zheng.   

Abstract

In addition to their overexpression in cancer cells, most of the tumor-associated Ags are expressed at low but detectable levels in normal tissues. It is not clear whether the repertoire of T cells specific for unmutated tumor Ags is shaped by negative selection during T cell development. The transgenic adenocarcinoma of mouse prostate (TRAMP) model is transgenic for the SV40 large T Ag (Tag) under the control of the rat probasin regulatory elements. Although it has been established that T lymphocytes from TRAMP mice are tolerant to SV40 Tag, the mechanism of the tolerance is largely unknown. To examine whether the T cell clonal deletion is responsible for the tolerance, we crossed the TRAMP mice with mice transgenic for a rearranged TCR specific for SV40 Tag presented by the H-2K(k). Double transgenic TRAMP/TCR mice showed profound thymic deletion of SV40 Tag-reactive T cells, including a 6- to 10-fold reduction in the total thymocyte numbers and a >50-fold reduction in phenotypically mature T cells. Consistent with this finding, we observed that the SV40 Tag and endogenous mouse probasin genes are expressed at low levels in the thymus. These results demonstrate that clonal deletion is a major mechanism for tolerance to Ags previously regarded as prostate-specific, and provide direct evidence that the T cell repertoire specific for an unmutated tumor Ag can be shaped by clonal deletion in the thymus.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12391185     DOI: 10.4049/jimmunol.169.9.4761

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Nonblocking Monoclonal Antibody Targeting Soluble MIC Revamps Endogenous Innate and Adaptive Antitumor Responses and Eliminates Primary and Metastatic Tumors.

Authors:  Shengjun Lu; Jinyu Zhang; Dai Liu; Guangfu Li; Kevin F Staveley-O'Carroll; Zihai Li; Jennifer D Wu
Journal:  Clin Cancer Res       Date:  2015-06-23       Impact factor: 12.531

2.  Androgen ablation mitigates tolerance to a prostate/prostate cancer-restricted antigen.

Authors:  Charles G Drake; Amy D H Doody; Marianne A Mihalyo; Ching-Tai Huang; Erin Kelleher; Sowmya Ravi; Edward L Hipkiss; Dallas B Flies; Eugene P Kennedy; Meixiao Long; Patrick W McGary; Lee Coryell; William G Nelson; Drew M Pardoll; Adam J Adler
Journal:  Cancer Cell       Date:  2005-03       Impact factor: 31.743

3.  Deletion is neither sufficient nor necessary for the induction of peripheral tolerance in mature CD8+ T cells.

Authors:  Jason R Lees; Bridget Charbonneau; Axel K Swanson; Robert Jensen; Jianfeng Zhang; Robert Matusik; Timothy L Ratliff
Journal:  Immunology       Date:  2006-02       Impact factor: 7.397

4.  In situ vaccination combined with androgen ablation and regulatory T-cell depletion reduces castration-resistant tumor burden in prostate-specific pten knockout mice.

Authors:  Elizabeth J Akins; Miranda L Moore; Shuai Tang; Mark C Willingham; Janet A Tooze; Purnima Dubey
Journal:  Cancer Res       Date:  2010-04-20       Impact factor: 12.701

5.  Whole-body irradiation increases the magnitude and persistence of adoptively transferred T cells associated with tumor regression in a mouse model of prostate cancer.

Authors:  Lindsay K Ward-Kavanagh; Junjia Zhu; Timothy K Cooper; Todd D Schell
Journal:  Cancer Immunol Res       Date:  2014-05-06       Impact factor: 11.151

6.  B7 blockade alters the balance between regulatory T cells and tumor-reactive T cells for immunotherapy of cancer.

Authors:  Penghui Zhou; Xincheng Zheng; Huiming Zhang; Yang Liu; Pan Zheng
Journal:  Clin Cancer Res       Date:  2009-02-01       Impact factor: 12.531

7.  In vivo expansion of the residual tumor antigen-specific CD8+ T lymphocytes that survive negative selection in simian virus 40 T-antigen-transgenic mice.

Authors:  Todd D Schell
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

8.  Targeting lymphotoxin-mediated negative selection to prevent prostate cancer in mice with genetic predisposition.

Authors:  Penghui Zhou; Xianfeng Fang; Beth A McNally; Ping Yu; Mingzhao Zhu; Yang-Xin Fu; Lizhong Wang; Yang Liu; Pan Zheng
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-23       Impact factor: 11.205

9.  iNKT cells control mouse spontaneous carcinoma independently of tumor-specific cytotoxic T cells.

Authors:  Matteo Bellone; Monica Ceccon; Matteo Grioni; Elena Jachetti; Arianna Calcinotto; Anna Napolitano; Massimo Freschi; Giulia Casorati; Paolo Dellabona
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

Review 10.  Telomerase as a Target for Therapeutic Cancer Vaccines and Considerations for Optimizing Their Clinical Potential.

Authors:  Espen Basmo Ellingsen; Sara M Mangsbo; Eivind Hovig; Gustav Gaudernack
Journal:  Front Immunol       Date:  2021-07-05       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.